Pura Vida Investments’s Zevra Therapeutics ZVRA Stock Holding History

Pura Vida Investments’s Portfolio ZVRA Stock Details ZVRA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	–	Sell	-3,750	Closed	-$390K	–	133
2018 Q2	$390K	Buy	+3,750	New	+$366K	0.16%	87

Other funds holding ZVRA

DSC Advisors Chicago, Illinois $11M AUM 5.88% 1-Year Est. Return

AWA

Arete Wealth Advisors Chicago, Illinois $1.33B AUM 25.12% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Creative Planning Overland Park, Kansas $147B AUM 18.73% 1-Year Est. Return

Cowen Inc New York $1.39B AUM 60.14% 1-Year Est. Return

Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Pura Vida Investments's ZVRA Position: Q3 2018 in Review

Pura Vida Investments sold out of Zevra Therapeutics (ZVRA) in Q3 2018, closing a stake of 3,750 shares — an estimated $390K sold.

Pura Vida Investments first reported a position in ZVRA in Q2 2018 and held it in 1 quarter. The position peaked at $390K in Q2 2018. 33 funds tracked by Wall St. Rank hold ZVRA as of Q3 2018.

Pura Vida Investments reported no remaining Zevra Therapeutics position as of Q3 2018 after selling out during the quarter.
Pura Vida Investments sold 3,750 Zevra Therapeutics shares in Q3 2018, an estimated $390K.
Pura Vida Investments first reported a position in Zevra Therapeutics in Q2 2018 and held it in 1 quarter.
Pura Vida Investments's Zevra Therapeutics position peaked at $390K in Q2 2018.
33 funds tracked by Wall St. Rank held Zevra Therapeutics as of Q3 2018.

Based on Pura Vida Investments's 13F filing for Q3 2018, filed 14 Nov 2018.